glp-1 obesity drugs news today 2025 As continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: โOzempic feet.โ Story๐below Americans turn to risky unregulated
Description
It has the same proposed mechanism: turning fiber into butyrate to support natural GLP-1 production
Strong demand for metabolic disorder therapies is expected to continue driving market progression over the forecast period
Weve already seen similar patterns with other GLP-1 medications, including oral semaglutide
Red areas indicate increased cFOS activity and blue areas indicate decreased cFOS activity
[50] Research [edit] In September 2024, it was reported that a study found that liraglutide helped children aged 6 to 12 years of age reduce their body mass index by 7.4% in a 56-week trial
